Risk minimization measures
Risk minimization measures
| Scientific Name | Brand name | Approval Date | Last Update | Details |
|---|---|---|---|---|
| Adalimumab | Hadlima | View | ||
| Dimethyl Fumarate | Defra | View | ||
| Teriflunomide | Axyla | View | ||
| Caplacizumab | Cablivi | View | ||
| Lomitapide | Lojuxta | View | ||
| Rivaroxaban | Banoriv | View | ||
| Eliglustat | Cerdelga | View | ||
| Pegcetacoplan | Empaveli | View | ||
| Canakinumab | Ilaris | View | ||
| Rivaroxaban | Xarelto | View |